HeimORX • STO
add
Orexo AB
Við síðustu lokun
30,45 kr.
Dagbil
29,20 kr. - 30,50 kr.
Árabil
12,50 kr. - 43,40 kr.
Markaðsvirði
1,06 ma. SEK
Meðalmagn
108,89 þ.
V/H-hlutf.
-
A/V-hlutfall
-
Aðalkauphöll
STO
Viðskiptafréttir
Um
Orexo is a Swedish pharmaceutical company that develops improved pharmaceuticals based on innovative formulation technologies that meet large medical needs. Through presence its in the US market, drugs and digital therapies are commercialized to treat opioid use disorder and adjacent diseases. Products targeting other therapeutic areas are developed and commercialized worldwide with partners. Wikipedia
Framkvæmdastjóri
Stofnsett
1995
Vefsvæði
Starfsfólk
104